https://www.indianpharmapost.com/glenmark-launches-lobeglitazone-in-india-for-uncontrolled-type-2-diabetes-in-adults-131242022-10-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/presss-note-on-who-medical-product-alert-regarding-maiden-pharmaceuticals-131252022-10-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/zydus-receives-final-approval-from-usfda-and-180-days-shared-exclusivity-for-brivaracetam-tablets-131262022-10-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/lt-construction-bags-order-to-construct-manufacturing-facility-in-haryana-131272022-10-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/lupin-appoints-dr-shahin-fesharaki-as-global-chief-scientific-officer-131282022-10-07T00:00:00+05:30always0.9